Filing Details
Perspective Therapeutics, Inc. (AMEX:CATX) filed a Form 8-K with the Securities and Exchange Commission on October 08, 2026, disclosing a material event.
Perspective Therapeutics, Inc. (AMEX:CATX) filed a Form 8-K with the Securities and Exchange Commission on October 08, 2026, disclosing a material event.

At publication ·
Perspective Therapeutics, Inc. (AMEX:CATX) · 8k filed
At a glance
Perspective Therapeutics, Inc. (AMEX:CATX) filed a Form 8-K with the Securities and Exchange Commission on October 08, 2026, disclosing a material event.
Perspective Therapeutics, Inc.'s stock currently trades at $2.71 with a market capitalization of $200.3M. The Healthcare company's stock moved following the disclosure.
8-K filings report material events that shareholders should know about between regular quarterly or annual reports. These can include leadership changes, material agreements, acquisitions, asset sales, or changes to financial guidance. The specific nature of the event determines its significance for Perspective Therapeutics, Inc.'s stock.
All SEC filings for Perspective Therapeutics, Inc. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View CATX Stock Page
Browse all filings on our CATX SEC filings page.
Public companies like Perspective Therapeutics, Inc. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.
Keep reading
analyst ·
analyst ·
analyst ·
earnings ·
Current market data
AMEX · CATX
$2.66
Down: -$0.05 · -1.85%
Live quote updated